Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Minimal Residual Disease MRD

  • Atezolizumab Plus ctDNA MRD Testing Wins FDA Approval to Improve Outcomes in Muscle-Invasive Bladder Cancer
    May 18, 2026

    Atezolizumab Plus ctDNA MRD Testing Wins FDA Approval to Improve Outcomes in Muscle-Invasive Bladder Cancer

    Dr. C H Weaver MD
  • ctDNA Recurrence Monitoring in Endometrial Cancer
    August 29, 2025

    ctDNA Recurrence Monitoring in Endometrial Cancer

    Dr. C H Weaver MD
  • Learn how ctDNA testing can help inform breast cancer management
    August 28, 2025

    Learn how ctDNA testing can help inform breast cancer management

    Dr. C H Weaver MD
  • MRD ctDNA Surveillance for Breast Cancer Recurrence
    August 28, 2025

    MRD ctDNA Surveillance for Breast Cancer Recurrence

    Dr. C H Weaver MD
  • Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging
    June 28, 2025

    Liquid Biopsy Detects Cancer Progression Much Earlier Than Imaging

    Dr. C H Weaver MD
  • Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer
    August 9, 2024

    Ask the Experts About Circulating Tumor DNA in the Management of Colorectal Cancer

    Dr. C H Weaver MD
  • Understanding Cancer Diagnostic Tests: From Early Detection to Personalized Treatment Planning
    March 25, 2024

    Understanding Cancer Diagnostic Tests: From Early Detection to Personalized Treatment Planning

    Dr. C H Weaver MD
  • ctDNA Residual Disease Assessment in Lymphoma
    December 29, 2023

    ctDNA Residual Disease Assessment in Lymphoma

    Dr. C H Weaver MD
  • Learn how ctDNA testing can help inform management of lung cancer
    November 8, 2023

    Learn how ctDNA testing can help inform management of lung cancer

    Dr. C H Weaver MD
  • Ask The Experts About ctDNA Surveillance Monitoring-Changing the Management of Melanoma
    September 1, 2023

    Ask The Experts About ctDNA Surveillance Monitoring-Changing the Management of Melanoma

    Dr. C H Weaver MD
  • How Precision Medicine in Oncology Has Dramatically Changed the Way Cancer is Diagnosed and Treated
    January 27, 2023

    How Precision Medicine in Oncology Has Dramatically Changed the Way Cancer is Diagnosed and Treated

    Dr. C H Weaver MD
  • Liquid Biopsies Improve Treatment of Lung Cancer
    December 9, 2020

    Liquid Biopsies Improve Treatment of Lung Cancer

    Dr. C H Weaver MD
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...